| (+)-alpha-tocopherol | affects localization | EXP | | 6480464 | alpha-Tocopherol affects the localization of DIABLO protein | CTD | PMID:15582575 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:2321120 | 6480464 | epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of DIABLO protein] | CTD | PMID:17936647 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1310885 | 6480464 | epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of DIABLO protein] | CTD | PMID:17936647 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of DIABLO mRNA | CTD | PMID:20702594 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2321120 | 6480464 | 2,4-dinitrotoluene affects the expression of DIABLO mRNA | CTD | PMID:21346803 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:1310885 | 6480464 | 2,4-dinitrotoluene affects the expression of DIABLO mRNA | CTD | PMID:21346803 |
| 2,6-di-tert-butyl-4-methylphenol | multiple interactions | ISO | RGD:2321120 | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of DIABLO protein]; more ... | CTD | PMID:14987999 |
| 2,6-di-tert-butyl-4-methylphenol | multiple interactions | ISO | RGD:1310885 | 6480464 | Butylated Hydroxytoluene inhibits the reaction [ganglioside, GD3 results in increased secretion of DIABLO protein]; more ... | CTD | PMID:14987999 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:2321120 | 6480464 | 2,6-dinitrotoluene affects the expression of DIABLO mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:1310885 | 6480464 | 2,6-dinitrotoluene affects the expression of DIABLO mRNA | CTD | PMID:21346803 |
| 5-fluorouracil | increases response to substance | ISO | RGD:1322043 | 6480464 | DIABLO protein results in increased susceptibility to Fluorouracil | CTD | PMID:18031615 |
| 5-fluorouracil | increases expression | ISO | RGD:1322043 | 6480464 | Fluorouracil results in increased expression of DIABLO mRNA | CTD | PMID:16557594 |
| acetylsalicylic acid | decreases expression | ISO | RGD:1322043 | 6480464 | Aspirin results in decreased expression of DIABLO protein | CTD | PMID:15976387 |
| adenosine | increases expression | ISO | RGD:1322043 | 6480464 | Adenosine results in increased expression of DIABLO mRNA; more ... | CTD | PMID:20063052 |
| adenosine | multiple interactions | ISO | RGD:1322043 | 6480464 | Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO mRNA]; more ... | CTD | PMID:20063052 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1322043 | 6480464 | [Tretinoin co-treated with Paclitaxel] affects the localization of DIABLO protein | CTD | PMID:18098270 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1322043 | 6480464 | Tretinoin results in increased expression of DIABLO protein | CTD | PMID:17701358 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1322043 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in increased expression of DIABLO protein | CTD | PMID:17701358 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1322043 | 6480464 | [Tretinoin co-treated with zoledronic acid] results in decreased expression of DIABLO protein | CTD | PMID:20349282 |
| ammonium chloride | increases expression | ISO | RGD:2321120 | 6480464 | Ammonium Chloride results in increased expression of DIABLO protein | CTD | PMID:16483693 |
| ammonium chloride | increases expression | ISO | RGD:1310885 | 6480464 | Ammonium Chloride results in increased expression of DIABLO protein | CTD | PMID:16483693 |
| cadmium dichloride | affects localization | EXP | | 6480464 | Cadmium Chloride affects the localization of DIABLO protein | CTD | PMID:19887573 |
| cadmium dichloride | increases expression | ISO | RGD:2321120 | 6480464 | Cadmium Chloride results in increased expression of DIABLO mRNA | CTD | PMID:21297351 |
| chrysazin | increases expression | ISO | RGD:1322043 | 6480464 | danthron results in increased expression of DIABLO protein | CTD | PMID:21126053 |
| cisplatin | increases response to substance | ISO | RGD:1322043 | 6480464 | DIABLO protein results in increased susceptibility to Cisplatin | CTD | PMID:21204765 PMID:18031615 |
| cisplatin | increases response to substance | ISO | RGD:1322043 | 6480464 | DIABLO protein results in increased susceptibility to Cisplatin | CTD | PMID:18031615 PMID:21204765 |
| cladribine | multiple interactions | ISO | RGD:1322043 | 6480464 | Cladribine promotes the reaction [bendamustine results in increased localization of DIABLO protein] | CTD | PMID:12948851 |
| clofibric acid | multiple interactions | ISO | RGD:1310885 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DIABLO mRNA | CTD | PMID:17602206 |
| clofibric acid | multiple interactions | ISO | RGD:2321120 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DIABLO mRNA | CTD | PMID:17602206 |
| curcumin | affects localization | EXP | | 6480464 | Curcumin affects the localization of DIABLO protein | CTD | PMID:17277231 |
| curcumin | increases response to substance | EXP | | 6480464 | DIABLO protein results in increased susceptibility to Curcumin | CTD | PMID:17277231 |
| dasatinib (anhydrous) | multiple interactions | ISO | RGD:1322043 | 6480464 | [NVP-AEW541 co-treated with dasatinib] affects the localization of DIABLO protein | CTD | PMID:20664932 |
| dasatinib (anhydrous) | affects localization | ISO | RGD:1322043 | 6480464 | dasatinib affects the localization of DIABLO protein | CTD | PMID:20664932 |
| dexamethasone | affects localization | ISO | RGD:1322043 | 6480464 | Dexamethasone affects the localization of DIABLO protein | CTD | PMID:12855565 |
| dexamethasone | multiple interactions | ISO | RGD:1322043 | 6480464 | [GCS-100 co-treated with Dexamethasone] affects the localization of DIABLO protein | CTD | PMID:16166312 |
| dioxygen | multiple interactions | ISO | RGD:1322043 | 6480464 | 3-hydroxy-4-pentenoic acid promotes the reaction [Oxygen deficiency results in increased secretion of DIABLO protein] | CTD | PMID:17671207 |
| dipyridamole | multiple interactions | ISO | RGD:1322043 | 6480464 | Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO protein]; more ... | CTD | PMID:20063052 |
| doxorubicin | increases expression | ISO | RGD:1322043 | 6480464 | Doxorubicin results in increased expression of DIABLO mRNA | CTD | PMID:17521628 |
| folic acid | increases expression | EXP | | 6480464 | Folic Acid results in increased expression of DIABLO mRNA; more ... | CTD | PMID:12969128 |
| hydrogen peroxide | multiple interactions | ISO | RGD:2321120 | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of DIABLO protein] | CTD | PMID:14987999 |
| hydrogen peroxide | increases secretion | ISO | RGD:1310885 | 6480464 | Hydrogen Peroxide results in increased secretion of DIABLO protein | CTD | PMID:14987999 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1310885 | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of DIABLO protein] | CTD | PMID:14987999 |
| hydrogen peroxide | increases secretion | ISO | RGD:2321120 | 6480464 | Hydrogen Peroxide results in increased secretion of DIABLO protein | CTD | PMID:14987999 |
| imatinib | multiple interactions | ISO | RGD:1322043 | 6480464 | [imatinib co-treated with flavopiridol] results in increased secretion of DIABLO protein | CTD | PMID:12231544 |
| indole-3-methanol | affects expression | ISO | RGD:2321120 | 6480464 | indole-3-carbinol affects the expression of DIABLO mRNA | CTD | PMID:21396975 |
| lamivudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of DIABLO mRNA | CTD | PMID:18313992 |
| minocycline | multiple interactions | ISO | RGD:2321120 | 6480464 | Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of DIABLO protein] | CTD | PMID:12930891 |
| minocycline | multiple interactions | ISO | RGD:1310885 | 6480464 | Minocycline results in decreased secretion of and results in decreased expression of DIABLO protein | CTD | PMID:14998631 |
| minocycline | multiple interactions | ISO | RGD:1310885 | 6480464 | Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of DIABLO protein] | CTD | PMID:12930891 |
| minocycline | decreases secretion | EXP | | 6480464 | Minocycline results in decreased secretion of DIABLO protein | CTD | PMID:12930891 |
| minocycline | multiple interactions | ISO | RGD:2321120 | 6480464 | Minocycline results in decreased secretion of and results in decreased expression of DIABLO protein | CTD | PMID:14998631 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1310885 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DIABLO mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2321120 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DIABLO mRNA | CTD | PMID:17602206 |
| nitric oxide | affects localization | ISO | RGD:1322043 | 6480464 | Nitric Oxide affects the localization of DIABLO protein | CTD | PMID:15126337 |
| ochratoxin A | decreases expression | ISO | RGD:1322043 | 6480464 | ochratoxin A results in decreased expression of DIABLO mRNA | CTD | PMID:17316727 |
| paclitaxel | affects localization | ISO | RGD:1322043 | 6480464 | Paclitaxel affects the localization of DIABLO protein | CTD | PMID:18098270 |
| paclitaxel | multiple interactions | ISO | RGD:1322043 | 6480464 | [resveratrol co-treated with Paclitaxel] affects the localization of DIABLO protein | CTD | PMID:14749477 |
| paclitaxel | multiple interactions | ISO | RGD:1322043 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in increased expression of DIABLO protein | CTD | PMID:17701358 |
| paclitaxel | multiple interactions | ISO | RGD:1322043 | 6480464 | [Tretinoin co-treated with Paclitaxel] affects the localization of DIABLO protein | CTD | PMID:18098270 |
| paclitaxel | increases expression | ISO | RGD:1322043 | 6480464 | Paclitaxel results in increased expression of DIABLO protein | CTD | PMID:17701358 |
| paracetamol | affects localization | EXP | | 6480464 | Acetaminophen affects the localization of DIABLO protein | CTD | PMID:17906064 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of DIABLO mRNA | CTD | PMID:17562736 |
| paraquat | multiple interactions | ISO | RGD:2321120 | 6480464 | epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of DIABLO protein] | CTD | PMID:17936647 |
| paraquat | increases expression | ISO | RGD:1310885 | 6480464 | Paraquat results in increased expression of DIABLO protein | CTD | PMID:17936647 |
| paraquat | multiple interactions | ISO | RGD:1310885 | 6480464 | epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of DIABLO protein] | CTD | PMID:17936647 |
| paraquat | increases expression | ISO | RGD:2321120 | 6480464 | Paraquat results in increased expression of DIABLO protein | CTD | PMID:17936647 |
| perfluorooctanoic acid | increases expression | ISO | RGD:2321120 | 6480464 | perfluorooctanoic acid results in increased expression of DIABLO mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | increases expression | ISO | RGD:1310885 | 6480464 | perfluorooctanoic acid results in increased expression of DIABLO mRNA | CTD | PMID:19162173 |
| phenethyl isothiocyanate | multiple interactions | ISO | RGD:1322043 | 6480464 | Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein]; more ... | CTD | PMID:16054126 |
| phenethyl isothiocyanate | affects binding | ISO | RGD:1322043 | 6480464 | DIABLO protein binds to phenethyl isothiocyanate | CTD | PMID:21838287 |
| phenethyl isothiocyanate | increases metabolic processing | ISO | RGD:1322043 | 6480464 | phenethyl isothiocyanate results in increased metabolism of DIABLO protein | CTD | PMID:21838287 |
| phenethyl isothiocyanate | affects localization | ISO | RGD:1322043 | 6480464 | phenethyl isothiocyanate affects the localization of DIABLO protein | CTD | PMID:16054126 |
| pterostilbene | increases expression | ISO | RGD:1322043 | 6480464 | pterostilbene results in increased expression of DIABLO protein | CTD | PMID:22450950 PMID:22572619 |
| pterostilbene | affects localization | ISO | RGD:1322043 | 6480464 | pterostilbene affects the localization of DIABLO protein | CTD | PMID:22572619 |
| resveratrol | affects localization | ISO | RGD:1322043 | 6480464 | resveratrol affects the localization of DIABLO protein | CTD | PMID:17636462 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of DIABLO protein | CTD | PMID:15837718 |
| resveratrol | multiple interactions | ISO | RGD:1322043 | 6480464 | [resveratrol co-treated with Paclitaxel] affects the localization of DIABLO protein | CTD | PMID:14749477 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of DIABLO protein | CTD | PMID:17872969 |
| simvastatin | affects localization | ISO | RGD:1322043 | 6480464 | Simvastatin affects the localization of DIABLO protein | CTD | PMID:20045437 |
| simvastatin | multiple interactions | ISO | RGD:1322043 | 6480464 | DIABLO protein promotes the reaction [Simvastatin results in increased activity of CASP9 protein] | CTD | PMID:20045437 |
| sirolimus | multiple interactions | ISO | RGD:1322043 | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] affects the localization of DIABLO protein; more ... | CTD | PMID:15767555 |
| spermine | affects localization | ISO | RGD:1322043 | 6480464 | Spermine affects the localization of DIABLO protein | CTD | PMID:16151648 |
| thapsigargin | affects response to substance | ISO | RGD:1322043 | 6480464 | DIABLO protein affects the susceptibility to Thapsigargin | CTD | PMID:16382148 |
| thapsigargin | affects localization | ISO | RGD:1322043 | 6480464 | Thapsigargin affects the localization of DIABLO protein | CTD | PMID:15339911 |
| trans-resveratrol | affects localization | ISO | RGD:1322043 | 6480464 | resveratrol affects the localization of DIABLO protein | CTD | PMID:17636462 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of DIABLO protein | CTD | PMID:17872969 |
| trans-resveratrol | multiple interactions | ISO | RGD:1322043 | 6480464 | [resveratrol co-treated with Paclitaxel] affects the localization of DIABLO protein | CTD | PMID:14749477 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of DIABLO protein | CTD | PMID:15837718 |
| zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of DIABLO mRNA | CTD | PMID:18313992 |
| zoledronic acid | multiple interactions | ISO | RGD:1322043 | 6480464 | [Tretinoin co-treated with zoledronic acid] results in decreased expression of DIABLO protein | CTD | PMID:20349282 |